A recently formed pharmaceutical spinoff will slash 20% of its workforce as it tries to cut at least $1 billion in costs over the next few years.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.